AJP - GI AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (August 24, 2006). doi:10.1152/ajpgi.00278.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/G323    most recent
00278.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drake, S. F
Right arrow Articles by Trinder, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drake, S. F
Right arrow Articles by Trinder, D.
Submitted on June 22, 2006
Accepted on August 21, 2006

Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3

Sarah F Drake1, Evan H Morgan2, Carly E Herbison3, Roheeth D Delima3, Ross M Graham3, Anita CG Chua3, Peter J Leedman4, Robert Fleming5, Bruce R Bacon6, John K Olynyk7, and Debbie Trinder7*

1 Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Perth, Western Australia, Australia
2 Biomedical and Chemical Sciences, University of Western Australia, Perth, Western Australia, Australia
3 Perth, Western Australia, Australia; Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Perth, Western Australia, Australia
4 Laboratory for Cancer Medicine, Centre for Medical Research, Western Australian Institute for Medical Research, University of Western Australia, Western Australia, Australia; Medicine and Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, Western Australia, Australia
5 Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri, United States
6 Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, United States
7 Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Perth, Western Australia, Australia; Western Australia Institute for Medical Research, Perth, Western Australia, Australia

* To whom correspondence should be addressed. E-mail: dtrinder{at}cyllene.uwa.edu.au.

Hereditary hemochromatosis (HH) type 3 is an iron (Fe) overload disorder caused by mutations in transferrin receptor 2 (TfR2). TfR2 is expressed highly in the liver and regulates Fe metabolism. The aim of this study was to investigate duodenal Fe absorption and hepatic Fe uptake in a TfR2 (Y245X) mutant mouse model of HH type 3. Duodenal Fe absorption and hepatic Fe uptake were measured in vivo using 59Fe-ascorbate in TfR2 mutant mice, wild-type mice, and Fe-loaded wild-type mice (2% dietary carbonyl Fe). Gene expression was measured by real-time RT-PCR. Liver non-heme Fe concentration increased progressively with age in TfR2 mutant mice compared with wild-type mice. Fe absorption (both duodenal Fe uptake and transfer) was increased in TfR2 mutant mice compared with wild-type mice. Likewise, expression of genes participating in duodenal Fe uptake (Dcytb, DMT1) and transfer (ferroportin) were increased in TfR2 mutant mice. Nearly all the absorbed Fe was taken up rapidly by the liver. Despite hepatic Fe loading, hepcidin expression was decreased in TfR2 mutant mice compared with wild-type mice. Even when compared with Fe-loaded wild-type mice, TfR2 mutant mice had increased Fe absorption, increased duodenal Fe transport genes expression, increased liver Fe uptake, and decreased liver hepcidin expression. In conclusion, despite systemic Fe loading, Fe absorption and liver Fe uptake were increased in TfR2 mutant mice in association with decreased expression of hepcidin. These findings support a model in which TfR2 is a sensor of Fe status and regulates duodenal Fe absorption and liver Fe uptake.




This article has been cited by other articles:


Home page
J. Nutr.Home page
B. Chung, T. Chaston, J. Marks, S. K. Srai, and P. A. Sharp
Hepcidin Decreases Iron Transporter Expression in Vivo in Mouse Duodenum and Spleen and in Vitro in THP-1 Macrophages and Intestinal Caco-2 Cells
J. Nutr., August 1, 2009; 139(8): 1457 - 1462.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. Pelucchi, R. Mariani, P. Trombini, S. Coletti, M. Pozzi, V. Paolini, D. Barisani, and A. Piperno
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2
Haematologica, February 1, 2009; 94(2): 276 - 279.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K.-S. Min, H. Ueda, T. Kihara, and K. Tanaka
Increased Hepatic Accumulation of Ingested Cd is Associated with Upregulation of Several Intestinal Transporters in Mice Fed Diets Deficient in Essential Metals
Toxicol. Sci., November 1, 2008; 106(1): 284 - 289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. F. Wallace, L. Summerville, E. M. Crampton, and V. N. Subramaniam
Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C383 - C390.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan, and T. Ganz
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4
Blood, September 15, 2007; 110(6): 2182 - 2189.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.